Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY 4.0PLOS One

A high intensity vs. casual speed walking intervention to reverse frailty among older adults: a cluster randomized controlled trial

6 affiliations
  1. 1Department of Physical Therapy and Human Movement Sciences, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States of America
  2. 2Department of Anesthesia and Critical Care, University of Chicago, Chicago, Illinois, United States of America
  3. 3School of Kinesiology, University of Michigan, Ann Arbor, Michigan, United States of America
  4. 4Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
  5. 5Department of Preventive Medicine (Biostatistics), Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
  6. 6Department of Physical Therapy & Human Movement Sciences and McCormick School of Engineering, Northwestern University, Chicago, Illinois, United States of America

Abstract

Interventions to reduce frailty and promote healthy aging are critical to improving quality of life and reducing disability in older adults. Walking is the most common form of exercise among older adults; however, the optimal walking intensity for prefrail and frail adults remains unclear. We conducted a cluster-randomized, assessor- and participant-blinded trial to determine whether high-intensity walking (HIW) improves frailty more than casual-speed walking (CSW). Fourteen retirement communities were randomized to either HIW or CSW using a modified minimal sufficient balance randomization scheme. We recruited 165 prefrail and frail adults aged ≥60 years, of whom 105 were included in the analytic cohort. Participants were able to ambulate at least 10 feet with moderate assistance or less. The HIW group targeted 70% of heart rate maximum (HRmax), while the CSW group walked at self-selected speeds below 60% HRmax. Supervised walking sessions were 45 minutes, three times per week, for 16 weeks. The primary outcome was improvement by at least one frailty category on the SHARE-FI (Survey of Health Among Retired Europeans – Frailty Index). Secondary outcomes included the Timed Up and Go, Short Physical Performance Battery, Berg Balance Scale, and 6-Minute Walk Test (6MWT), measured at baseline and 16 weeks. Participants had a mean (SD) age of 79.2 (8.0) years; 79% were female, and 75% were non-Hispanic White. Improvement in frailty category occurred in 32 of 46 (69.6%) HIW participants versus 26 of 56 (46.4%) CSW participants (OR = 2.91, 95% CI 1.19–7.13, p = 0.02). HIW participants showed greater gains in gait speed (mean difference = 0.08 m/s, 95% CI 0.03–0.13, p = 0.036) and 6MWT distance (mean difference = 48.99 m, 95% CI 21.1–76.9, p = 0.0088). Mean HRmax was 71% in HIW vs. 59% in CSW (p < 0.001). Median completed sessions were similar (HIW = 35; CSW = 36; p = 0.07). This cluster-randomized trial demonstrates that high-intensity walking can reverse frailty more effectively than casual-speed walking due to increased physiologic stimuli during more intensive activity. This study is registered at ClinicalTrials.gov ID NCT03654807 (https://clinicaltrials.gov/study/NCT03709251) Registered 10/12/2018.

Related

  1. Moderate-intensity exercise versus high-intensity interval training to determine the optimal training intensity for walking rehabilitation in chronic stroke (HIT-Stroke Trial 2): a study protocol for a randomized controlled trial
    Christina Garrity, Darcy S. Reisman, Sandra A. Billinger +18
    TrialsPeer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
  2. A pilot randomized controlled trial of melatonin supplementation on plasma 2-arachidonoylglycerol, ghrelin, and hedonic appetite intensity in females with overweight/obesity
    Malihe Karamizadeh, Maryam Parimi, Leila Sadeghi +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyCrossref
  3. Effects of Hidden Conditioning and Positive Expectations on Pain Intensity Following Spinal Manipulative Therapy: A Three‐Arm Randomized Controlled Trial
    Helen Cristina Nogueira Carrer, Thamiris Costa de Lima, Bianca Emanuelli Saes Campanha +4
    European journal of pain (London, England)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Feasibility and Exploratory Outcomes of Foot‐Ankle and Walking Exercises for Diabetic Neuropathy, Stress, and Quality of Life: A Pilot Randomized Controlled Trial
    Siti Fadlilah, Wahyu Rochdiat Murdhiono, Ariyanto Nugroho +5
    Research in Nursing & HealthPeer-reviewedCC BY-NC-ND 4.0Full text2 citedEndocrinology & metabolismPMC
  5. Effect of a Researcher‐Supervised Walking Program With Smartphone‐Based Step Monitoring on Sleep Quality in Older Psychiatric Inpatients: A Randomized Controlled Trial
    Samin Khoshnoud Speily, Roya Mansour‐Ghanaei, Robabeh Soleimani +1
    Health science reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCDOAJ
BibTeX
@article{danilovich2026high,
  title = {{A high intensity vs. casual speed walking intervention to reverse frailty among older adults: a cluster randomized controlled trial}},
  author = {Margaret Danilovich and Daniel S. Rubin and David E. Conroy and Laura Diaz and Ying Cheung and Daniel Corcos and Lauren Balmert Bonner},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0357605},
  url = {https://doi.org/10.1371/journal.pone.0357605},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A high intensity vs. casual speed walking intervention to reverse frailty among older adults: a cluster randomized controlled trial
AU  - Margaret Danilovich
AU  - Daniel S. Rubin
AU  - David E. Conroy
AU  - Laura Diaz
AU  - Ying Cheung
AU  - Daniel Corcos
AU  - Lauren Balmert Bonner
PY  - 2026
DA  - 2026/09/30
JO  - PLOS One
DO  - 10.1371/journal.pone.0357605
UR  - https://doi.org/10.1371/journal.pone.0357605
AB  - Interventions to reduce frailty and promote healthy aging are critical to improving quality of life and reducing disability in older adults. Walking is the most common form of exercise among older adults; however, the optimal walking intensity for prefrail and frail adults remains unclear. We conducted a cluster-randomized, assessor- and participant-blinded trial to determine whether high-intensity walking (HIW) improves frailty more than casual-speed walking (CSW). Fourteen retirement communities were randomized to either HIW or CSW using a modified minimal sufficient balance randomization scheme. We recruited 165 prefrail and frail adults aged ≥60 years, of whom 105 were included in the analytic cohort. Participants were able to ambulate at least 10 feet with moderate assistance or less. The HIW group targeted 70% of heart rate maximum (HRmax), while the CSW group walked at self-selected speeds below 60% HRmax. Supervised walking sessions were 45 minutes, three times per week, for 16 weeks. The primary outcome was improvement by at least one frailty category on the SHARE-FI (Survey of Health Among Retired Europeans – Frailty Index). Secondary outcomes included the Timed Up and Go, Short Physical Performance Battery, Berg Balance Scale, and 6-Minute Walk Test (6MWT), measured at baseline and 16 weeks. Participants had a mean (SD) age of 79.2 (8.0) years; 79% were female, and 75% were non-Hispanic White. Improvement in frailty category occurred in 32 of 46 (69.6%) HIW participants versus 26 of 56 (46.4%) CSW participants (OR = 2.91, 95% CI 1.19–7.13, p = 0.02). HIW participants showed greater gains in gait speed (mean difference = 0.08 m/s, 95% CI 0.03–0.13, p = 0.036) and 6MWT distance (mean difference = 48.99 m, 95% CI 21.1–76.9, p = 0.0088). Mean HRmax was 71% in HIW vs. 59% in CSW (p < 0.001). Median completed sessions were similar (HIW = 35; CSW = 36; p = 0.07). This cluster-randomized trial demonstrates that high-intensity walking can reverse frailty more effectively than casual-speed walking due to increased physiologic stimuli during more intensive activity. This study is registered at ClinicalTrials.gov ID NCT03654807 (https://clinicaltrials.gov/study/NCT03709251) Registered 10/12/2018.
SN  - 1932-6203
ER  -